RohitKKatialMD

Clinical & Laboratory Immunology

Professor of Medicine, National Jewish Health; University of Colorado

Dr. Katial is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
1400 Jackson St
Denver, CO 80206
Phone+1 303-388-4461

Fax+1 303-270-2206

National Capital ConsortiumFellowship, Clinical and Laboratory Immunology, 1996 - 1997
Fitzsimons Army Medical CenterFellowship, Allergy and Immunology, 1994 - 1996
Dwight David Eisenhower Army Medical CenterResidency, Internal Medicine, 1991 - 1994
Georgetown University School of MedicineClass of 1991

Sub-Sensitivity to Long-Acting Bronchodilators (LABA) Start of enrollment: 2010 Mar 01
Completed
Not Applicable
Long-acting Beta Agonist Step Down Study Start of enrollment: 2012 Mar 01
Completed
Phase 4

PubMed

88 citations
Efficacy and safety of dupilumab in perennial allergic rhinitis and comorbid asthma.
Steven Weinstein, Rohit K. Katial, Shyamalie Jayawardena, Gianluca Pirozzi, Heribert Staudinger
The Journal of Allergy and Clinical Immunology. 2018-07-01
333 citations
Effects of benralizumab on airway eosinophils in asthmatic patients with sputum eosinophilia
Michel Laviolette, David Gossage, Gail M. Gauvreau, Richard Leigh, Ron Olivenstein
The Journal of Allergy and Clinical Immunology. 2013-11-01
217 citations
Safety profile, pharmacokinetics, and biologic activity of MEDI-563, an anti–IL-5 receptor α antibody, in a phase I study of subjects with mild asthma
William W. Busse, Rohit K. Katial, David Gossage, Suha Sari, Bing Wang
The Journal of Allergy and Clinical Immunology. 2010-06-01

Journal Articles

Original Article Effects of Reslizumab on Asthma Outcomes in a Subgroup of Eosinophilic Asthma Patients with Self-Reported Chronic Rhinosinusitis with Nasal Polyps
Rohit K Katial, Margaret Garin, Steven F Weinstein, ScienceDirect

Lectures

Clinical Communications zxcvbnUS Trends in Mortality Rates for Primary Immunodeficiency Diseases
American College of Physicians, Albuquerque, New York - 10/25/2012
Clinical Communications zxcvbnUS Trends in Mortality Rates for Primary Immunodeficiency Diseases
Eastern Allergy Conference, Palm Beach, Florida - 5/30/2013

Add-on Reslizumab Lowers Asthma Exacerbation Rates in Aspirin-Sensitive PatientsMarch 4th, 2017
CDC Wonders ‘Is It Really A Penicillin Allergy?’March 21st, 2016
High Ozone and Pollen Levels Could Worsen AllergiesMay 13th, 2015
Join now to see all